Location History:
- Mountain View, AL (US) (2016)
- Mountain Brook, AL (US) (2021 - 2023)
Company Filing History:
4 out of 647 
3 out of 203 
Years Active: 2016-2023
Title: Anath Shalev: Innovator in Diabetes Research
Introduction
Anath Shalev is a prominent inventor based in Mountain Brook, Alabama. He has made significant contributions to the field of diabetes research, holding a total of 4 patents. His work focuses on developing innovative compounds that can potentially transform the treatment of diabetes and related disorders.
Latest Patents
One of Anath Shalev's latest patents involves substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors. This invention discloses compounds and compositions that inhibit TXNIP expression and lower hepatic glucose production. The disclosed compounds can be beneficial for disorders associated with elevated TXNIP and glucagon levels, such as diabetes and its associated complications. Additionally, methods for treating hyperlipidemia or fatty liver disease, which may be linked to elevated TXNIP and glucagon levels, are also provided. This abstract serves as a scanning tool for searching in the relevant field and is not intended to limit the present invention.
Career Highlights
Anath Shalev has worked with notable organizations, including the UAB Research Foundation and Southern Research Institute. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the medical field.
Collaborations
Throughout his career, Anath has collaborated with esteemed colleagues such as Corinne E Augelli-Szafran and Omar Moukha-Chafiq. These collaborations have further enriched his research and development efforts.
Conclusion
Anath Shalev's innovative work in diabetes research and his contributions to the development of TXNIP inhibitors highlight his role as a key inventor in the field. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.